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ABSTRACT 13 
Tetrahydrocurcumin (THC) is one of the major colourless metabolites of curcumin and 14 
shows even greater pharmacological and physiological benefits. The aim of this work 15 
was the manufacturing of porous scaffolds as a carrier of THC under physiological 16 
conditions. Fish-derived gelatin scaffolds were prepared by freeze-drying by two 17 
solutions concentrations (2.5% and 4% w/v), cross-linked via addition of lactose and 18 
heat-treated at 105 ¡C. This cross-linking reaction resulted in more water resistant 19 
scaffolds with a water uptake capacity higher than 800%. Along with the cross-linking 20 
reaction, the gelatin concentration affected the scaffold morphology, as observed by 21 
scanning electron microscopy images, by obtaining a reduced porosity but larger pores 22 
sizes when the initial gelatin concentration was increased. These morphological 23 
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changes led to a scaffoldÕs strength enhancement from 0.92±0.22MPa to 2.04±0.18MPa 24 
when gelatin concentration was increased. THC release slowed down when gelatin 25 
concentration increased from 2.5 to 4%w/v, showing a controlled profile within 96 h. 26 
Preliminary in vitro test with chondrocytes on scaffolds with 4%w/v gelatin offered higher 27 
metabolic activities and cell survival up to 14 days of incubation. Finally the addition of 28 
THC did not influence significantly the cytocompatibility and potential antibacterial 29 
properties were demonstrated successfully against Staphylococcus aureus. 30 
KEYWORDS: Tetrahydrocurcumin; gelatin; lactose; scaffolds; antibacterial. 31 
1. Introduction 32 
Porous scaffolds are crucial for many biomedical and biological applications [1, 2]. In 33 
tissue engineering, compared with synthetic materials, natural polymers have been 34 
shown to favourably regulate division, adhesion, differentiation and migration of cells [3]. 35 
Gelatin was chosen as a base material because it is biocompatible, biodegradable, non-36 
carcinogenic, less antigenic than collagen, and commercially available at relatively low 37 
cost [4, 5]. Moreover, it is recognised as safe material by the Food and Drug 38 
Administration. Therefore, porous gelatin scaffolds have found many applications in 39 
tissue engineering research, e.g. for bone, skin, cartilage and nerve regeneration [6-10]. 40 
In particular, tissue engineering of articular cartilage in vitro is a promising strategy for 41 
cartilage repair, in order to tackle the difficulties related with the self-repair of articular 42 
cartilage due to its avascular tissue nature, low rate of chondrocyte proliferation and 43 
matrix turnover [11]. Porous scaffolds are used to support cell adhesion and 44 
proliferation and to guide formation of cartilage tissue. However, in vitro engineered 45 
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cartilage often has thickness limitation, heterogeneous cartilage extracellular matrix 46 
(ECM) and weak mechanical property which limit their clinical application [12, 13].  47 
In order to preserve structure and provide mechanical support to cells during tissue 48 
formation [14], a cross-linking of gelatin is required. Chemical cross-linking methods 49 
typically use chemicals such as aldehydes, aspartic and glutamic acids [15]. 50 
Additionally, physical cross-linking methods, such as heating, drying, and irradiation, are 51 
also commonly applied to proteins [16, 17]. In particular, in this work we considered the 52 
effect of heating in the presence of sugars on modifying the conformation and 53 
interactions within proteins, leading to a complex cross-linking process known as 54 
Maillard reaction or non-enzymatic glycation. The main variables affecting the extension 55 
of the Maillard reaction are temperature, time, initial pH, carbonyl/sugar ratio, and water 56 
activity [18-20]. So, these factors should be analysed in order to obtain the properties 57 
required for biomedical applications. 58 
Additionally, gelatin-based scaffolds can be used as a vehicle for the release of 59 
bioactive agents such as antioxidants, peptides, growth factors, antimicrobials and 60 
drugs [21-24]. In particular, infection is a major problem in orthopaedics leading to 61 
implant failure. Sources of infectious bacteria include the environment of the operating 62 
room, surgical equipment, clothing worn by medical and paramedical staff, resident 63 
bacteria on the patient's skin and bacteria already residing in the patientÕs body [25]. 64 
Implant-associated infections are the result of bacteria adhesion to an implant surface 65 
and subsequent biofilm formation at the implantation site [26]. In this work, we decided 66 
to evaluate the antibacterial properties of the crosslinked gelatin scaffolds with the 67 
incorporation of tetrahydrocurcumin (THC), a water-soluble, colourless and tasteless 68 
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antioxidant, antidiabetic, anticancer and anti-inflammatory plant-derived compound, that 69 
is increasingly being used for pharmaceutical, medical and food applications [27, 28]. 70 
Literature reports only studies on the delivery of the hydrophobic compound curcumin to 71 
facilitate wound healing with the addition of ethanol in chitosan-alginate sponges [29] or 72 
cyclodextrins in slightly hydrated alginate foams in order to improve the distribution of 73 
curcumin [30]. 74 
Therefore, beyond the state of the art, this is the first work where gelatin-based 75 
scaffolds, prepared by freeze-drying, were cross-linked by using lactose. Lactose is a 76 
disaccharide occurring almost exclusively in the milk of mammals with important 77 
nutritional and probiotic properties and is mainly used in various food, nutrition and 78 
pharmaceutical formulations [31]. In this study, lactose was used as a cross-linker in 79 
order to promote the Maillard reaction, between the carbonyl group of lactose and the 80 
gelatin amino group, and to improve the mechanical stability of the gelatin scaffolds. 81 
Furthermore, THC was added to the initial gelatin solution to analyse the release of the 82 
bioactive compound from the gelatin scaffold and its antibacterial effect in the presence 83 
of the common nosocomial and joint-replacement/ wound infecting organisms 84 
Pseudomonas aeuroginosa and Staphylococcus aureus. 85 
This work aimed at studying the effect of initial gelatin concentration, cross-linking 86 
reaction and THC addition on the physico-chemical, mechanical and biological 87 
characteristics of porous gelatin scaffolds as potential medical device in 88 
musculoskeletal tissue regeneration.  89 
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2. Materials and methods 90 
2.1 Materials 91 
A commercial cod fish gelatin type A was employed in this study. It has bloom 200, 92 
11.06% moisture and 0.147% ash. Fish gelatin was kindly supplied by Weishardt 93 
International (Liptovsky Mikulas, Slovakia) and meets the quality standard for edible 94 
gelatin (1999/724/CE). Glycerol and lactose (Panreac, Barcelona, Spain) were used as 95 
plasticizer and cross-linking agent, respectively. Tetrahydrocurcumin was gifted by 96 
Sabinsa Corporation (East Windsor, New Jersey, USA) and was used as bioactive 97 
agent. 98 
2.2 Scaffold preparation  99 
2.5 and 4% w/v fish gelatin porous scaffolds were prepared by freeze-drying. Firstly, 100 
2.5 g or 4 g gelatin and 20 wt% lactose (on gelatin dry basis) were dissolved in 100 mL 101 
distilled water for 30 min at 80 ¡C under continuous stirring to obtain a homogenous 102 
blend. After that, a mixture of 10 wt% glycerol and 5 wt% THC (on gelatin dry basis) 103 
was added to the solution, pH was adjusted to 10 with 1 N NaOH and the solution was 104 
placed in an ultrasonic device (USC300TH, VWR International, USA) at room 105 
temperature for 5 min. Subsequently, the solution was maintained at 80 ¼C for 30 min 106 
under stirring, 2 mL solution was poured into each well of a 24 multiwell plate (Costar 107 
3526, Corning Incorporated, USA) and the plate was kept in the fridge at 4 ¼C to cool 108 
down. Once the solution was gelled, the plate was kept in a freezer at -20 ¼C for 48 h 109 
and then, freeze-dried for 48 h (Alpha 1-2 LDplus, CHRIST, Germany). Finally, non-110 
heated (NH) scaffolds were taken out from the wells and 1 day later some of them were 111 
heat-treated (HT) at 105 ¼C for 24 h in an oven (Carbolite 3000, Carbolite Gero, UK) in 112 
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order to promote the Maillard cross-linking reaction [32-34]. As verified in a previous 113 
work [27], these conditions do not affect the thermal stability of gelatin and THC. The 114 
samples containing THC and heat-treated were coded as HT-THC. 115 
2.3 Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy 116 
FTIR spectra were obtained using a Spectrum Two PE instrument equipped with a 117 
horizontal attenuated total reflectance (ATR) crystal (ZnSe) (PerkinElmer Inc., USA). 118 
The samples were placed directly onto the ATR crystal and spectra were collected in 119 
transmittance mode. Each spectrum was the result of the average of 32 scans at 4 cm−1 120 
resolution. Measurements were recorded in the wavelength range of 1800-800 cm−1. All 121 
spectra were smoothed using the Savitzky-Golay function. Second-derivative spectra of 122 
the amide region were used at bands position guides for the curve fitting procedure, 123 
using OriginPro 9.1 software. 124 
2.4 Compression test 125 
Mechanical tests were performed using a mechanical testing machine (EZ-SX, 126 
Shimadzu, Japan) equipped with a 500 N load cell, as described in a previous work 127 
[35]. Test specimens were cylinder-shaped scaffolds with a 1.3 cm diameter and an 128 
average height of around 1 cm. The crosshead speed was set at 1 mm·min−1, and the 129 
load was applied until the specimen was compressed to around 80% of its original 130 
height before break. Compression resistance of five dried samples for each composition 131 
was evaluated at room temperature and the stress was calculated by dividing the 132 
applied force with the initial scaffold surface area, whereas strain was calculated from 133 
the displacement of the scaffolds in relation to the original thickness. YoungÕs modulus 134 
(E) was also calculated as the slope of the linear elastic regime (0-15%). 135 
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2.5 Scanning electron microscopy (SEM) 136 
SEM (Hitachi TM3030 Tabletop, Germany) equipped with Energy Dispersive 137 
Spectroscopy (EDS) was utilised to study the scaffold inner morphology. The samples 138 
were cut into small squares, fixed on the aluminium stub using carbon tape. For pore 139 
size evaluation SEM images were analysed by ImageJ software. 140 
2.6 Water uptake (WU) measurements 141 
WU was calculated gravimetrically according to ASTM D570-98 [36] under 142 
physiological conditions. Three specimens of each composition were weighed (W0) and 143 
immersed in 6 mL of a phosphate buffered saline (PBS) solution at pH 7.0 in order to 144 
determine the WU profile at 37¡C in an incubator (INCU-Line, VWR). Then, the samples 145 
were removed from the buffer solution at fixed times, wiped with a paper and reweighed 146 
(Wt). WU was calculated using the following equation [37]: 147 
WU! ! !
!!!!!
!!
!100          Eq.1 148 
A graph depicting WU against time was plotted in order to determine the equilibrium 149 
swelling. 150 
2.7 Degradation test 151 
The degradation degree (DD) was calculated gravimetrically under physiological 152 
conditions. Three specimens of each composition were weighed (WI) and immersed in 6 153 
mL of a PBS solution at pH 7.0 in order to determine the degradation at 37 ¡C in an 154 
incubator. Samples were removed from the buffer solution once swelling test ended, 155 
wiped with a paper, left to dry at room temperature for 24 h and reweighed (WF). DD 156 
was calculated using the following equation: 157 
!!! ! =1!
!!
!!
!100          Eq.2 158 
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2.8 THC release 159 
UV-Vis spectroscopy is one of the methods to determine the release and 160 
concentration of bioactives in buffer solutions. Firstly, the wavelength of maximum 161 
absorbance for THC in PBS was measured (ʎmax 280 nm) and then, standard solutions 162 
of THC were prepared over a concentration range (0.31250-0.00977 mg/mL) to 163 
establish a calibration curve (y=0.0314 + 2.2012x, R2=0.9985).  164 
THC release was determined by immersion of a quarter of a scaffold in 6 mL of a PBS 165 
solution (pH 7.0) at 37 ¡C in an incubator. At particular time intervals (1, 2, 4, 8, 24, 28 166 
and 96 h), aliquots of buffer (3 mL) were withdrawn, replaced with fresh buffer and 167 
analysed by UVÐVis spectroscopy (Lambda 2S Perkin Elmer) at 280 nm. All tests were 168 
carried out in triplicate and the results were expressed as % of released THC with 169 
respect to the THC incorporated in the scaffold by employing the calibration curve. 170 
2.9 Biological characterisation 171 
2.9.1 Cell culture 172 
Chondrocytes cells were differentiated from Human Bone Marrow Stromal Cells (Y201) 173 
and cultured according the protocol described by Genever et al.[38] at 37 ¡C, 5% CO2, 174 
in Chondrocyte Growth Medium ready-to-use (PromoCell, UK). 175 
In order to perform biocompatibility assays, the scaffolds were prepared according the 176 
same procedure explained in 2.2 section with few modifications. Once gelatin solution 177 
was prepared, 1 mL was poured into each well of a 48 multiwell plate in order to get 178 
smaller scaffolds, which were subsequently cut in samples of 8 mm diameter and an 179 
average height of around 2.5 mm. Each sample was put into a membrane-based cell 180 
culture insert (Millicell, membrane pore size of 0.8 µm, Merck, Millipore, Germany). This 181 
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insertion was carried out in a class 2 laminar flow hood and each insert was placed in a 182 
well of a 24 multiwell plate. Afterwards, the plate was placed below the UV light for 30 183 
min in order to keep it sterile. A suspension of 20x104 cells in Growth medium was 184 
seeded dropwise (in 500 µL) on the top surface of the scaffolds and incubated at 37 ¡C, 185 
5% CO2 for 30 min. Then, fresh medium was added up to1 mL volume. 186 
2.9.2 Cytocompatibility study 187 
The Presto Blue assay was exploited to test the metabolic activity of cells seeded on 188 
the scaffolds after 1, 3, 7 and 14 days of culture. A LS-50B Luminescence Spectrometer 189 
(Perkin Elmer, Waltham, MA) was used to measure the fluorescence (560 nm excitation 190 
and 590 nm emission) after 5 h of incubation with a 10% aliquot of Presto Blue (Thermo 191 
Scientific, USA). The obtained values were corrected subtracting the average 192 
fluorescence of control wells. Results were expressed as mean ± standard deviation. 193 
2.9.3 Cell fixation and probe staining for confocal microscopy 194 
Three and seven days after seeding cells on the scaffolds, cells were fixed using 4% 195 
paraformaldehyde (Sigma Life Science) for 15 min at room temperature. Cells were 196 
washed three times using 0.1% DPBS/Tween 20 (Sigma Life Science), followed by a 197 
20-min light-protected incubation period at room temperature with phalloidin (1 mg/mL, 198 
Sigma Life Science). After three new washes with 0.1% DPBS/Tween 20, 4′,6-199 
diamidino-2-phenylindole (DAPI; 1:2500 solution, Vector Laboratories) was added, and 200 
the solution was subjected to a 10-min light-protected incubation period at room 201 
temperature. Afterwards, cells were washed and resuspended in 500 µL of 0.1% 202 
DPBS/Tween 20. Fixed cells were protected from light and stored at 4 ¡C. Cells were 203 
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visualised using a Leica TCS SP2 UV AOBS MP (Upright) point scanning confocal 204 
microscope (Leica Microsystems) at 20× magnification. 205 
2.10 Antibacterial tests 206 
Antimicrobial activity of the scaffolds was tested against Staphylococcus aureus (S. 207 
aureus) NCTC 8325 and a clinical strain of Pseudomonas aeruginosa (P. aeruginosa) 208 
(SOM-1, Stafford group culture collection). Fresh 4 h cultures of S. aureus strain 8325 209 
and a clinical P. aeruginosa isolate (Sheffield culture collection) were grown in Brain 210 
Heart Infusion broth (Oxoid) at 37¡C (OD600 0.4-0.6) and spread onto Columbia 211 
nutrient agar plates. After drying for 10 min, 8 mm HT gelatin scaffolds of both 212 
concentration with or without THC were placed on the surface of the agar plates, which 213 
were then incubated for 24 h at 37 ¡C before being photographed. 214 
2.11 Statistical analysis 215 
Data were subjected to one-way analysis of variant (ANOVA) by means of a SPSS 216 
computer program (SPSS Statistic 20.0). Post hoc multiple comparisons were 217 
determined by the TukeyÕs test with the level of significance set at *p < 0.05 and **p < 218 
0.01. 219 
3. Results and discussion 220 
3.1. Physicochemical characterisation 221 
ATR-FTIR analysis was carried out in order to evaluate the gelatin-lactose and 222 
gelatin-THC interactions. The relative spectra are shown in Figure 1A and 1B. The 223 
main absorption bands were located in the spectral range from 1630 to 800 cm-1. 224 
Gelatin bands were related to C=O stretching at 1630 cm-1 (amide I), N-H bending at 225 
1530 cm-1 (amide II) and C-N stretching at 1230 cm-1 (amide III) [39]. The main 226 
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absorption bands of glycerol were related to the five peaks corresponding to the 227 
vibrations of C-C bonds at 850, 940 and 1000 cm-1 and C-O bonds at 1050 and 1100 228 
cm-1 [40]. The bands associated with lactose were located between 1180 and 953 cm-1, 229 
where the bands at 979 and 987 cm-1 were referred to the vibration of C-C, and the 230 
band at 1034 cm-1 was associated with the vibration of C-O in CH2-OH group [41]. 231 
Finally, the characteristic bands of THC corresponding to C=C stretching of aromatic 232 
rings (1600-1400 cm−1) and associated to C-O stretching of hydroxyl groups (1300-1000 233 
cm−1) cannot be clearly distinguished due the overlapping with the bands of gelatin and 234 
glycerol [42]. 235 
As can be observed in Figure 1A and 1B, the two bands situated in the range of 236 
1100-1000 cm-1 tend to become a single band in HT scaffolds irrespective of gelatin 237 
concentration, indicating the chemical reaction between gelatin and lactose, as shown 238 
in previous works [32, 33]. As can be seen in Scheme 1, this cross-linking reaction is a 239 
condensation reaction between the carbonyl group of lactose and the amino group of 240 
gelatin, mainly the amino group of lysine [43, 44]. 241 
Regarding THC addition, the band corresponding to amide II showed a shoulder at 242 
lower frequencies, attributed to the hydrogen bonding between the hydroxyl groups of 243 
THC and the amino groups of proline and hydroxyproline in gelatin [45]. Additionally, the 244 
bands in the range of 1100-1000 cm-1 were clearly distinguishable, indicating that THC 245 
addition could hinder the chemical reaction between gelatin and lactose due to steric 246 
hindrance. The band corresponding to amide I depends on the secondary structure of 247 
the protein backbone and is the most commonly used band for the quantitative analysis 248 
of conformational changes [46]. Therefore, the areas of the bands at 1624 cm-1, 1650 249 
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cm-1, and 1680 cm-1 as a function of protein concentration and heat treatment were 250 
measured and shown in Figure 1C. As can be observed, the protein concentration did 251 
not have great influence on NH scaffolds; however, it affected the secondary structure 252 
of the protein in HT scaffolds. The increase of the bands at 1624 cm-1 and 1680 cm-1 in 253 
HT scaffolds with 4% w/v gelatin could be related to a higher cross-linking degree in the 254 
scaffolds with higher gelatin content. Regarding THC addition, the secondary structure 255 
of the protein was affected to a lesser extent. This behaviour could be associated with a 256 
lower cross-linking degree due to the fact that THC could hinder the cross-linking 257 
reaction, irrespective of gelatin concentration. 258 
Freeze-drying is a process in which a solvent is removed from a frozen product by a 259 
sublimation process under vacuum, the removal of water could be influenced by the 260 
initial gelatin concentration. As the dry product has smaller specific area at higher solute 261 
concentrations, the removal of the absorbed water is more difficult (Figure S1), 262 
requiring longer times to finish the secondary drying step [47]. Thus, the amount of 263 
residual water present in gelatin scaffolds after freeze-drying could vary as a function of 264 
the initial gelatin concentration, having a significant impact on the extension of cross-265 
linking reaction. In fact, moisture content is believed to be an important factor since 266 
moisture can increase chains' mobility and, thus, the rate of chemical reaction [48].  267 
3.2. Mechanical and morphological characterisation 268 
In order to assess the effects of the initial gelatin concentration, THC addition and 269 
cross-linking on mechanical properties of the scaffolds, the stress-strain curves, 270 
obtained by compression tests at 0-80% strain, were analysed and the results are 271 
shown in Figure 2A. All the samples presented the typical trend of porous scaffolds, in 272 
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which the stress-strain curve is comprised of three regions with different mechanical 273 
behaviour: (i) the linear proportion of the stress-strain curve at low strain values is 274 
related to the elastic behaviour of the material; (ii) the region at intermediate strain 275 
values is related to the viscoelastic behaviour of the scaffold; and (iii) the curve at high 276 
strain values is related to the densification process [49]. It is worth noting that increasing 277 
the initial gelatin concentration and promoting the cross-linking reaction by heating 278 
notably reinforced the scaffolds, indicating the relevance of these two factors[50]. As 279 
can be seen in Figure 2B, the stress values at 40% strain for the gelatin scaffolds 280 
without THC were significantly (p < 0.05) different. In fact, the strength enhancement 281 
with respect to NH scaffolds with 2.5% w/v gelatin was 134% for HT scaffolds with 2.5% 282 
w/v gelatin, 163% for NH scaffolds with 4% w/v gelatin, and 218% for HT scaffolds with 283 
4% w/v gelatin. Regarding THC addition, a decrease in the scaffold reinforcement was 284 
observed, which could be related to a lower cross-linking degree between gelatin and 285 
lactose, as shown by ATR-FTIR. In fact, at 40% strain, the stress values of HT-THC 286 
scaffolds with 2.5% w/v gelatin and 4% w/v gelatin were significantly (p < 0.05) lower 287 
than those of HT scaffolds. 288 
The YoungÕs modulus of each scaffold was also calculated. Although 2.5% w/v 289 
scaffolds did not show significant (p > 0.05) changes after both heat treatment and THC 290 
addition, scaffolds prepared with 4% w/v gelatin presented a significant (p < 0.05) 291 
increase after heat treatment. This could be due to a higher degree of cross-linking 292 
between gelatin and lactose. However, the addition of THC slightly decreased the 293 
modulus value due to its possible effect in slowing down the cross-linking reaction. 294 
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However, the obtained scaffolds presented suitable mechanical properties for cartilage 295 
tissue engineering applications [51-53]. 296 
As freeze-drying is one of the most effective methods to create numerous cavities 297 
within the bulk material, SEM analysis was performed on the fractured sections of the 298 
scaffolds to evaluate the effect of the initial gelatin concentration, THC addition and the 299 
heat treatment on the morphology and porosity of the scaffolds (Figure 3). It is worth 300 
mentioning that the initial gelatin concentration notably affected the scaffolds porosity. 301 
NH samples prepared with 2.5% w/v gelatin (Figure 3A) presented a homogeneous 302 
porous matrix with small pores, which could provide more surface area for cell 303 
adhesion. In contrast, a less porous structure with larger pores was shown when gelatin 304 
concentration was increased up to 4% w/v (Figure 3D); this could facilitate nutrition 305 
supply and waste removal [54]. The porosity and the pore size of the scaffolds 306 
fabricated by freeze-drying are largely dependent on parameters such as the 307 
water:polymer ratio and the viscosity of the solution [55]. In fact, when the initial gelatin 308 
concentration increased, the volume fraction occupied by the material itself also 309 
increased, affecting the porosity of the material [56]. Regarding heat treatment (Figure 310 
3B and E), the reaction between gelatin and lactose led to more porous structures, 311 
which presented lower pore size when THC was added (Figure 3C and F) mainly in 4% 312 
w/v gelatin scaffolds. 313 
As the distribution of the pore sizes is influenced by the composition, ImageJ 314 
computer software was used to analyse SEM images and measure the pore sizes by 315 
means of an estimation of the cross-sectional area of the scaffold [57]. Figure 4A 316 
shows the average pore size of the scaffolds as a function of initial gelatin 317 
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concentration, THC addition and heat treatment. As can be observed, 2.5% w/v 318 
scaffolds did not present notable changes in the average pore size while an increase in 319 
pore size was observed when initial gelatin concentration increased. In fact, NH and HT 320 
samples prepared with 4% w/v gelatin presented 2- and 3-fold average pore size with 321 
larger pores (∼ 197 µm and 170 µm ) than NH and HT 2.5% w/v scaffolds (∼ 86 µm and 322 
65 µm), respectively. Regarding THC addition, samples prepared with 2.5% w/v gelatin 323 
did not present significant (p > 0.05) changes while 4% w/v scaffolds pore size notable 324 
decreased. This could be related to a higher volume occupied by the material in 325 
samples prepared with 4% w/v gelatin.  326 
The mean pore size distribution of the scaffolds as a function of initial gelatin 327 
concentration, THC addition and heat treatment is shown in Figure 4B. In the case of 328 
NH, HT and HT-THC scaffolds prepared with 2.5% w/v gelatin, around 74%, 66% and 329 
62% of pores were in the size range of 50-100 µm, respectively. When gelatin 330 
concentration was increased, it was observed a large number of pores in the size 331 
ranges of 150-250 µm, 100-250 µm and 50-150 µm. These results indicated that gelatin 332 
concentration, THC addition and heat treatment notable affected the pore size 333 
distribution of scaffolds. Thus, NH and HT 4% w/v scaffolds showed bigger pore size, 334 
which could explain lower deformation values [10], as shown by compression results. 335 
Regarding THC addition, a decrease in pores size was observed which could be related 336 
to a higher compaction of these scaffolds.  337 
3.3. Water uptake, degradation and THC release 338 
WU measurements were carried out in order to determine the effect of the initial 339 
gelatin concentration, THC addition and the heat treatment on the water absorption 340 
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capacity of the scaffolds. As can be observed in Figure S2, NH scaffolds with 2.5% w/v 341 
gelatin were completely dissolved after 30 min of immersion in PBS at 37 ¼C and 342 
considered not suitable, while HT and HT-THC scaffolds with 2.5% w/v gelatin 343 
maintained their physical integrity, demonstrating the effect of heating to promote cross-344 
linking reaction [32]. Similar behaviour was observed for the scaffolds with 4% w/v 345 
gelatin (data not shown). 346 
WU capacities of HT and HT-THC scaffolds were analysed as a function of gelatin 347 
concentration and the results are shown in Figure 5. As can be seen, gelatin 348 
concentration notably affected the WU capacity. Although both HT scaffolds increased 349 
their weight up to 400% after only 1 h of incubation in PBS, 4% w/v scaffolds (Figure 350 
5B) took twice as long (48 h) to reach the same WU (∼ 770%) as the 2.5% w/v scaffolds 351 
(Figure 5A). However, WU results showed high absorption capacity (> 800%) for the 352 
scaffolds prepared with both concentrations. These WU results showed that the 353 
scaffolds were hydrophilic in nature with capacity to hold a large amount of water 354 
molecules. However, the ability of the scaffold to hold water molecules within its network 355 
is dependent on the architecture of the scaffolds [58]. The longer stability of HT 356 
scaffolds with 4% w/v gelatin in PBS at 37 ¼C could be related to a higher cross-linking 357 
degree, lower porosity and higher compaction, which could slow down the absorption of 358 
liquid, leading to longer times (> 336 h) than the scaffolds with 2.5% w/v (72 h) before 359 
complete dissolution. 360 
With regard to THC addition, an increase in the scaffold WU capacity was observed, 361 
irrespective of gelatin concentration. In fact, WU values of the scaffolds with 4% w/v 362 
gelatin increased up to 843 ± 20%, while the values of the scaffolds with 2.5% w/v 363 
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gelatin presented a higher capacity to retain water (946 ± 72%) after 48 h of incubation. 364 
This faster WU for HT-THC scaffolds with 2.5% w/v gelatin can be due to the lower 365 
cross-linking degree and compaction of these scaffolds. It is also worth noting that the 366 
addition of THC facilitated the disintegration of scaffolds. 367 
Scaffold degradation degree (DD) was calculated as well and the results are shown in 368 
Figure 5C. With respect to NH scaffolds, DD values notably decreased up to 67.5 ± 369 
0.2% and 12.1 ± 2.5% for the HT scaffolds with 2.5 and 4% w/v gelatin, respectively, 370 
after 72 and 336 h of incubation in PBS at 37 ¼C. This decrease was related to the 371 
cross-linking reaction between gelatin and lactose. Since the degree of cross-linking 372 
and compaction were higher for the scaffolds with 4% w/v gelatin, as shown by ATR-373 
FTIR and SEM results, these scaffolds showed lower DD values. Regarding THC 374 
addition, the scaffolds with 2.5% w/v gelatin were totally degraded, while the scaffolds 375 
with 4% w/v gelatin presented a degradation value of 54.6 ± 5.6% after 72 and 336 h of 376 
incubation in PBS, respectively. As previously explained, the increase in the 377 
degradation values of HT-THC scaffolds could be related to a lower extension of the 378 
cross-linking reaction due to formation of physical bonds between the hydroxyl groups 379 
of THC and the amino groups of proline and hydroxyproline in gelatin, which could 380 
hinder the cross-linking reaction, resulting in higher DD values of HT-THC scaffolds 381 
than those of HT scaffolds. 382 
Finally, the THC release was analysed by UV-Vis spectroscopy and the results are 383 
shown in Figure 6. As can be seen, in the first 8 h 82 ± 4% THC was released from 384 
2.5% w/v scaffolds while 64 ± 9% was released from 4% w/v scaffolds. This decrease in 385 
THC release could be due to a higher physical interaction between gelatin and THC, a 386 
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more extensive chemical reaction and a higher structural compaction in 4% w/v 387 
scaffolds that slowed down the release of the bioactive. The high release of the anti-388 
inflammatory bioactive in the first 8 h could contribute to reduce the early postoperative 389 
inflammation, improving the cartilage healing. Furthermore, the release of THC from 390 
scaffolds continued increasing slightly over time since 2.5% w/v scaffolds presented a 391 
complete THC release after 96 h of immersion due to scaffolds total degradation while 392 
4% w/v scaffolds showed a lower THC release values (79 ± 9%). This controllable long 393 
release of the anti-inflammatory compound could be an effective intra-articular drug 394 
delivery method for the postoperative inflammation and pain management [59]. 395 
3.4. Biological characterisation 396 
Due to the poor water stability of NH scaffolds, the biological characterisation was 397 
only carried out for HT and HT-THC scaffolds as a function of gelatin concentration in 398 
order to analyse the viability of those scaffolds as cell substrate materials. Cell 399 
metabolic activity as well as cell morphology are shown in Figure 7. The metabolic 400 
activity on both gelatin concentrations presented a similar behaviour being higher for the 401 
2.5% w/v scaffolds without the presence of THC. The seeded chondrocytes presented 402 
their metabolic activity peak on day 7, decreasing afterwards due to the high cell 403 
confluence (as statistically significantly evident for the control represented by cells 404 
seeded on Tissue Cultured Plate, TCP). It is important to note that the metabolic activity 405 
on THC scaffolds was lower due to the THC presence; however, once released 406 
(approximately 98 h as shown previously in section 3.3), cells achieved their maximum 407 
metabolic activity. This is also related to the lower metabolic activity observed in the 4% 408 
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w/v scaffolds, since their THC release was slower when compared to the 2.5% w/v 409 
scaffolds. 410 
Phalloidin and Dapi stainings was performed to study the cell morphology and 411 
organisation within the different scaffolds. As shown in Figure 7, the cells seeded in 412 
both, 2.5 and 4% gelatin scaffolds, showed a high metabolic activity and spreading at 413 
day 3; particularly with visualisation of typical polygon shape of young chondrocytes at 414 
4% gelatin [60, 61]. Subsequently, as the cells proliferated, it was possible to observe 415 
the formation of cellular clusters in the 4% w/v scaffolds, either in presence and 416 
absence of THC, upon 7 days of culture. Furthermore, cultured cells were gradually 417 
aggregating, retaining typical polygons shapes and creating large interspaces; 418 
suggesting a potential formation of lacuna-like cartilage [62]. In contrast, the cells in the 419 
TCP control and 2.5% gelatin groups showed lower expression of F-actin (phalloidin 420 
staining). This could be induced by the different level of gelatin and/or its biomechanical 421 
effects closer to natural cartilage tissues, by providing an environment with more 422 
favourable chondrogenic properties [63]. It is also verified that both gelatin 423 
concentrations, with or without THC, showed healthy and proliferating cells in the 424 
developed scaffolds. Interestingly, the stability and metabolic activity of the scaffolds in 425 
growth media improved up to 2 weeks when compared to TCP control group, and it 426 
could be that the specific biological properties of gelatin to promote cell adhesion and 427 
cell-maritx interactions enhanced the biological stability of scaffolds [64]. 428 
3.5. Antibacterial characterisation 429 
In order to test the potential antimicrobial activity of THC infiltrated disks as an 430 
additional feature of this material, we performed antimicrobial plate assays with disk-431 
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shaped scaffolds (8 mm diameter) in the presence of the common nosocomial and joint-432 
replacement/ wound infecting organisms S. aureus and P. aeruginosa. As shown in 433 
Figure 8, there was a slight antimicrobial action exhibited by the THC containing 434 
scaffolds with S. aureus in the area where the disks were placed (i.e. with the THC 435 
there was a less dense growth), seen by individual colonies being visible, whereas 436 
without the THC the bacteria grew all the way up to the scaffold. The same did not apply 437 
for P. aeruginosa. We therefore have preliminary evidence that these materials have 438 
possible antimicrobial capability that could augment their potential for clinical use in 439 
orthopaedic surgery, because S. aureus strains represent a significant proportion of all 440 
pathogens causing infections associated with orthopaedic implants, and the binding of 441 
S. aureus to host tissues and plasma proteins is of critical importance in the 442 
development of infections at the implant site [65]. 443 
4. Conclusions 444 
This study demonstrated the utility of lactose cross-linking and THC to modify and 445 
improve the physico-chemical properties of gelatin-based porous scaffolds for tissue 446 
engineering. The cross-linking reaction resulted in a more water stable scaffold with 447 
enhanced mechanical properties and high water uptake capacity (> 800%). Although 448 
porosity decreased with the increase of the initial gelatin concentration, the observed 449 
increase of pore size from 118 ± 40 µm to 254 ± 57 µm, along with the cross-linking 450 
reaction, reinforced the scaffolds, enhancing their mechanical properties. Results of in 451 
vitro THC release and antibacterial experiments demonstrated that the THC-loaded 452 
scaffolds were capable of effectively releasing THC in a controlled way, with 80% THC 453 
released within three days that may lead to the design of an appropriate drug delivery 454 
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method for the postoperative inflammation and pain management. Looking forward to 455 
the intended clinical use, the main advantage of the system reported here was the THC 456 
biocompatibility and antimicrobial potential with a tailored concentrations for relatively 457 
rapid release to achieve a therapeutic effect minimising the risk of systemic side effects. 458 
This study has therefore demonstrated that THC may be applied to the manufacture of 459 
medical devices, particularly embedded in gelatin porous scaffolds, and it possesses 460 
potential antimicrobial properties to augment itsÕ musculoskeletal applications. 461 
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Figure captions 469 
Figure 1 ATR-FTIR spectra of non-heated (NH), heat-treated (HT) and HT-THC 470 
scaffolds with (A) 2.5 and (B) 4% w/v gelatin; (C) measurement of the areas of the 471 
bands at 1624 cm-1, 1650 cm-1, and 1680 cm-1 as a function of protein concentration 472 
and heat treatment. 473 
Figure 2 (A) Stress-strain curves of non-heated (NH), heat-treated (HT) and HT-THC 474 
scaffolds with 2.5 and 4% w/v gelatin. (B) YoungÕs modulus and stress values 475 
(calculated at 40% strain). Two means followed by the same letter in the same 476 
parameter are not significantly (p > 0.05) different through the TukeyÕs multiple range 477 
test. n = 3 is the minimum number of replications. 478 
Figure 3 SEM micrographs of (A) non-heated (NH), (B) heat-treated (HT) and (C) HT-479 
THC scaffolds with 2.5% w/v gelatin and (D) NH, (E) HT and (F) HT-THC scaffolds with 480 
4% w/v gelatin. Bar = 200 µm. 481 
Figure 4 (A) Average pore size (µm) and (B) pore size distribution (%) of non-heated 482 
(NH) heat-treated (HT) and HT-THC scaffolds with 2.5 and 4% w/v gelatin. 483 
Figure 5 Water uptake (WU) values for heat-treated (HT) and HT-THC scaffolds with 484 
(A) 2.5 and (B) 4% w/v gelatin. (C) Scaffold degradation degree (DD) values calculated 485 
after immersion in PBS for different interval times. Two means followed by the same 486 
letter are not significantly (p > 0.05) different through the TukeyÕs multiple range test. n 487 
= 3 is the minimum number of replications. 488 
Figure 6 THC release from heat-treated (HT) scaffolds with 2.5 and 4% w/v gelatin. 489 
Figure 7 Metabolic activity and morphological study of cells seeded on the porous 490 
scaffolds. PrestoBlue assay of cells cultured on (A) 2.5% w/v and (B) 4% w/v gelatin 491 
porous scaffolds after 1, 3, 7 and 14 days. (C) Confocal microscopy images of 492 
chondrocytes cells after 3 and 7 days of culture. Scale bars: 75 µm. 493 
Figure 8 Representative macro-photograph showing growth inhibition of (A) 494 
Pseudomonas aeuroginosa and (B) Staphylococcus aureus  at 24 h by 2.5% w/v gelatin 495 
without and with THC addition (a and c), and 4% w/w gelatin without and with THC 496 
addition (b and d). 497 
Scheme 1. The early stage of the cross-linking reaction (gal=galactose). 498 
 499 
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C
Gelatin 
concentration
Scaffold 1624 cm-1 1650 cm-1 1680 cm-1
NH 35.7 60.1 4.2
2.5% w/v HT 42.1 52.3 5.6
HT-THC 40.9 54.4 4.7
NH 35.5 59.4 5.1
4.0% w/v HT 48.2 44.3 7.5
HT-THC 46.9 46.3 6.8
A B
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Figure 2 507 
 508 
 509 
  510 
Scaffold Stress (MPa) YoungÕs modulus (MPa)
2.5% w/v 4.0% w/v 2.5% w/v 4.0% w/v
NH 0.173 ± 0.006a 0.282 ± 0.04c 1.22 ± 0.18a 1.51 ± 0.04ab
HT 0.232 ± 0.011bc 0.377 ± 0.050d 1.42 ± 0.18ab 2.43 ± 0.48c
HT-THC 0.155 ± 0.003a 0.289 ± 0.014c 0.92 ± 0.22a 2.04 ± 0.18bc
A
B
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